Stoked Bio is an Ontario-based biotechnology company advancing Ontario-originated science and a platform aimed at creating new therapeutic classes. The company is developing anti-infectives, programs targeting microbiome-related conditions, a glioblastoma cancer program, and a novel treatment approach for Parkinson’s disease symptoms. It recently closed an oversubscribed $2.5M seed financing round to advance its portfolio and validate its platform and candidates. The announcement states the vast majority of the seed capital (99%) came from Ontario investors. Stoked Bio characterizes the funds as supporting continued program development and demonstration of efficacy against resistant diseases. No revenue, user, or other operating metrics were disclosed in the announcement.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

May 2026